ONLINE DATABASE SEARCH - HIV-LS-292-MEMO
1. 43040 HIV-LS-292; PUBMED-HIV-3/24/2004
Analysis of the Interactions Between HIV-1 and the Cellular Prion Protein in a Human Cell Line
Leblanc, P, Baas, D, and Darlix, JL
J Mol Biol 2004. 337(4): 1035-51
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15033368&dopt=abstract
2. 43041 HIV-LS-292; PUBMED-HIV-3/24/2004
The HIV-1 Nef Protein: How An AIDS Pathogenetic Factor Turns to a Tool for Combating AIDS
Schiavoni, I, Muratori, C, Piacentini, V, Giammarioli, AM, and Federico, M
Curr Drug Targets Immune Endocr Metabol Disord 2004. 4(1): 19-27
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15032622&dopt=abstract
3. 43042 HIV-LS-292; PUBMED-HIV-3/24/2004
Classification and Regression Trees-Studies of HIV Reverse Transcriptase Inhibitors
Daszykowski, M, Walczak, B, Xu, QS, Daeyaert, F, De Jonge, MR, Heeres, J, Koymans, LM, Lewi, PJ, Vinkers, HM, Janssen, PA, and Massart, DL
J Chem Inf Comput Sci 2004. 44(2): 716-726
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15032554&dopt=abstract
4. 43043 HIV-LS-292; PUBMED-HIV-3/24/2004
Synthesis and Biological Evaluation in Human Monocyte-Derived Macrophages of N-(N-Acetyl-l-cysteinyl)-S-acetylcysteamine Analogues with Potent Antioxidant and Anti-HIV Activities
Oiry, J, Mialocq, P, Puy, JY, Fretier, P, Dereuddre-Bosquet, N, Dormont, D, Imbach, JL, and Clayette, P
J Med Chem 2004. 47(7): 1789-1795
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15027871&dopt=abstract
5. 43044 HIV-LS-292; PUBMED-HIV-3/24/2004
Synthesis, Structure-Activity Relationships, and Mechanism of Drug Resistance of d- and l-beta-3'-Fluoro-2',3'-unsaturated-4'-thionucleosides as Anti-HIV Agents
Zhu, W, Chong, Y, Choo, H, Mathews, J, Schinazi, RF, and Chu, CK
J Med Chem 2004. 47(7): 1631-40
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15027854&dopt=abstract
6. 43045 HIV-LS-292; PUBMED-HIV-3/24/2004
Expression of HIV-1 integrase in CEM cells inhibits HIV-1 replication
Van Griensven, J, Zhan, X, Van MaeLe B, Pluymers, W, Michiels, M, De Clercq, E, Cherepanov, P, and Debyser, Z
J Gene Med 2004. 6(3): 268-77
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15026988&dopt=abstract
7. 43046 HIV-LS-292; PUBMED-HIV-3/24/2004
6-Aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays
Costi, R, Santo, RD, Artico, M, Roux, A, Ragno, R, Massa, S, Tramontano, E, La ColLa, M, Loddo, R, Marongiu, ME, Pani, A, and ColLa, PL
Bioorg Med Chem Lett 2004. 14(7): 1745-1749
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15026063&dopt=abstract
8. 43047 HIV-LS-292; PUBMED-HIV-3/24/2004
A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues
Arzumanov, A, Stetsenko, DA, Malakhov, AD, Reichelt, S, Sorensen, MD, Babu, BR, Wengel, J, and Gait, MJ
Oligonucleotides 2003. 13(6): 435-53
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15025911&dopt=abstract
9. 43048 HIV-LS-292; PUBMED-HIV-3/24/2004
Synthesis of Novel, Multivalent Glycodendrimers as Ligands for HIV-1 gp120
Kensinger, RD, Yowler, BC, Benesi, AJ, and Schengrund, CL
Bioconjug Chem 2004. 15(2): 349-358
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15025531&dopt=abstract
10. 43049 HIV-LS-292; EMBASE-HIV-3/24/2004
High Resolution Crystal Structures of HIV-1 Protease with a Potent Non-peptide Inhibitor (UIC-94017) Active against Multi-drug-resistant Clinical Strains
Tie, Yunfeng, Boross, Peter I, Wang, Yuan-Fang, Gaddis, Laquasha, Hussain, Azhar K, Leshchenko, Sofiya, Ghosh, Arun K, Louis, John M, Harrison, Robert W, and Weber, Irene T
Journal of Molecular Biology 2004. In Press, Uncorrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6WK7-4BXDKHH-1/2/b81ad1ce83769b800e8a6141f00ad826
11. 43050 HIV-LS-292; EMBASE-HIV-3/24/2004
Interaction of amiloride and one of its derivatives with Vpu from HIV-1: a molecular dynamics simulation
Lemaitre, V, Ali, R, Kim, CG, Watts, A, and Fischer, WB
FEBS Letters 2004. In Press, Uncorrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6T36-4BXDMJ5-2/2/17f37ff7632c975dc418d4c9a1b3a6bb
12. 43051 HIV-LS-292; EMBASE-HIV-3/24/2004
De novo design and synthesis of HIV-1 integrase inhibitors
Makhija, Mahindra T, Kasliwal, Rajesh T, Kulkarni, Vithal M, and Neamati, Nouri
Bioorganic & Medicinal Chemistry 2004. In Press, Corrected Proof
HYPERLINK: http://www.sciencedirect.com/science/article/B6TF8-4BX77WS-3/2/e133f0ac2672cf29d8eb3762017b894d
13. 43052 HIV-LS-292; PUBMED-HIV-3/24/2004
Drug-Resistant Variants That Evolve During Nonsuppressive Therapy Persist in HIV-1-Infected Peripheral Blood Mononuclear Cells After Long-Term Highly Active Antiretroviral Therapy
VerhofsteDe C, Noe, A, Demecheleer, E, De Cabooter, N, Van WanzeeLe F, Van Der Gucht, B, Vogelaers, D, and Plum, J
J Acquir Immune Defic Syndr 2004. 35(5): 473-483
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15021312&dopt=abstract
14. 43053 HIV-LS-292; PUBMED-HIV-3/24/2004
Actin filaments play an essential role for transport of nascent HIV-1 proteins in host cells
Sasaki, H, Ozaki, H, Karaki, H, and Nonomura, Y
Biochem Biophys Res Commun 2004. 316(2): 588-93
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15020258&dopt=abstract
15. 43054 HIV-LS-292; PUBMED-HIV-3/24/2004
A new method for analysis of AZT-triphosphate and nucleotide-triphosphates
Van Kampen, JJ, Fraaij, PL, Hira, V, Van Rossum, AM, Hartwig, NG, De Groot, R, and LuiDer TM
Biochem Biophys Res Commun 2004. 315(1): 151-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15013439&dopt=abstract
16. 43055 HIV-LS-292; EMBASE-HIV-3/24/2004
Crystal Structures of HIV-1 Reverse Transcriptases Mutated at Codons 100, 106 and 108 and Mechanisms of Resistance to Non-nucleoside Inhibitors
Ren, J, Nichols, CE, Chamberlain, PP, Weaver, KL, Short, SA, and Stammers, DK
Journal of Molecular Biology 2004. 336(3): 569-578
HYPERLINK: http://www.sciencedirect.com/science/article/B6WK7-4BD5GRJ-9/2/f2c45436e2125a03885043f73de59d05
17. 43056 HIV-LS-292; PUBMED-HIV-3/24/2004
A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor
Montembault, M, Vo-Thanh, G, Deyine, A, Fargeas, V, Villieras, M, Adjou, A, Dubreuil, D, Esquieu, D, Gregoire, C, Opi, S, Peloponese, JM, Campbell, G, Watkins, J, De Mareuil, J, Aubertin, AM, Bailly, C, Loret, E , and Lebreton, J
Bioorg Med Chem Lett 2004. 14(6): 1543-1546
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15006399&dopt=abstract
18. 43057 HIV-LS-292; PUBMED-HIV-3/24/2004
HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors
Mustata, GI, Brigo, A, and Briggs, JM
Bioorg Med Chem Lett 2004. 14(6): 1447-54
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15006380&dopt=abstract
19. 43058 HIV-LS-292; PUBMED-HIV-3/24/2004
Crucial amides for dimerization inhibitors of HIV-1 protease
Bowman, MJ and Chmielewski, J
Bioorg Med Chem Lett 2004. 14(6): 1395-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15006369&dopt=abstract
20. 43059 HIV-LS-292; PUBMED-HIV-3/24/2004
Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120
Chiba, H, Inokoshi, J, Nakashima, H, Omura, S, and Tanaka, H
Biochem Biophys Res Commun 2004. 316(1): 203-10
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15003531&dopt=abstract
21. 43060 HIV-LS-292; PUBMED-HIV-3/24/2004
Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance
Anderson, J, Banerjea, A, and Akkina, R
Oligonucleotides 2003. 13(5): 303-312
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15000821&dopt=abstract
22. 43061 HIV-LS-292; PUBMED-HIV-3/24/2004
The reverse transcriptase (RT) mutation V118I is associated with virologic failure on abacavir-based antiretroviral treatment (ART) in HIV-1 infection
Saberg, P, Koppel, K, Bratt, G, Fredriksson, EL, Hejdeman, B, Sitbon, G, and Sandstrom, E
Scand J Infect Dis 2004. 36(1): 40-5
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15000558&dopt=abstract
23. 43062 HIV-LS-292; PUBMED-HIV-3/24/2004
Cytotoxic and anti-HIV principles from the rhizomes of Begonia nantoensis
Wu, PL, Lin, FW, Wu, TS, Kuoh, CS, Lee, KH, and Lee, SJ
Chem Pharm Bull (Tokyo) 2004. 52(3): 345-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14993759&dopt=abstract
24. 43063 HIV-LS-292; PUBMED-HIV-3/24/2004
Rapid screening for HIV-1 protease inhibitor leads through X-ray diffraction
Pillai, B, Kannan, KK, Bhat, SV, and Hosur, MV
Acta Crystallogr D Biol Crystallogr 2004. 60(Pt 3): 594-596
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14993705&dopt=abstract
25. 43064 HIV-LS-292; EMBASE-HIV-3/24/2004
HIV-1 nef decreases CXCR4 expression on CD4+ T-lymphocytes*1
Kamchaisatian, W, Haraguchi, S, Good, RA, Day, NK, Emmanuel, P, Sleasman, JW, and Tangsinmankong, N
Journal of Allergy and Clinical Immunology 2004. 113(2, Supplement 1): S124
HYPERLINK: http://www.sciencedirect.com/science/article/B6WH4-4BRJ5RW-G5/2/2fe2f1e3fd82090ee94135b5b0d00e83
26. 43065 HIV-LS-292; WOS-HIV-3/14/2004
HIV viral resistance to antiretroviral drugs: Foreword
Ippolito, G
SCAND J INFECT DIS 2003. 35: 4
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189255700001
27. 43066 HIV-LS-292; WOS-HIV-3/14/2004
Synthesis and antiviral activity of betulonic acid amides and conjugates with amino acids
Flekhter, OB, Boreko, EI, Nigmatullina, LR, Tret'yakova, EV, Pavlova, NI, Baltina, LA, Nikolaeva, SN, Savinova, OV, Eremin, VF, Galin, FZ, and Tolstikov, GA
RUSS J BIOORG CHEM+ 2004. 30(1): 80-88
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189279900012
28. 43067 HIV-LS-292; WOS-HIV-3/14/2004
Design and synthesis of alpha Gal-conjugated peptide T20 as novel antiviral agent for HIV-immunotargeting
Naicker, KP, Li, HG, Heredia, A, Song, HJ, and Wang, LX
ORG BIOMOL CHEM 2004. 2(5): 660-664
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189235900007
29. 43068 HIV-LS-292; WOS-HIV-3/14/2004
The distribution of the HIV protease inhibitor, ritonavir, to the brain, cerebrospinal fluid, and choroid plexuses of the guinea pig
Anthonypillai, C, Sanderson, RN, Gibbs, JE, and Thomas, SA
J PHARMACOL EXP THER 2004. 308(3): 912-920
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189212300015
30. 43069 HIV-LS-292; WOS-HIV-3/14/2004
Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades
Zhang, MY, Shu, Y, Sidorov, I, and Dimitrov, DS
ANTIVIR RES 2004. 61(3): 161-164
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189131000003
31. 43070 HIV-LS-292; WOS-HIV-3/14/2004
Characterization of a naphthalene derivative inhibitor of retroviral integrases
Daniel, R, Myers, CB, Kulkosky, J, Taganov, K, Greger, JG, Merkel, G, Weber, IT, Harrison, RW, and Skalka, AM
AIDS RES HUM RETROV 2004. 20(2): 135-144
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189260200002
32. 43071 HIV-LS-292; WOS-HIV-3/14/2004
A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types
Lueders, KK, De Rosa, SC, Valentin, A , Pavlakis, GN, Roederer, M, and Hamer, DH
AIDS RES HUM RETROV 2004. 20(2): 145-150
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189260200003
33. 43072 HIV-LS-292; WOS-HIV-3/14/2004
A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection
Bogers, WMJM, Bergmeier, LA, Ma, J, Oostermeijer, H, Wang, YF, Kelly, CG, ten, Haaft P, Singh, M, Heeney, JL, and Lehner, T
AIDS 2004. 18(1): 25-36
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189101600003
34. 43073 HIV-LS-292; WOS-HIV-3/14/2004
Decline in HIV infectivity following the introduction of highly active antiretroviral therapy
Porco, TC, Martin, JN, Page-Shafer, KA, Cheng, A, Charlebois, E, Grant, RM, and Osmond, DH
AIDS 2004. 18(1): 81-88
HYPERLINK:
http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000189101600010